Acta Endoscopica

, Volume 16, Issue 3, pp 175–183 | Cite as

Dysplasie é pithé liale gastrique: ré sultats du dé pistage et d’ une surveillance systé matique

  • F. Cardin
  • F. Farinati
  • F. Di Mario
  • C. Arslan-Pagnini
  • M. Rugge
  • G. Penon
  • R. Naccarato

Résumé

Dans une série de 3 900 patients soumis à une gastroscopie, la fréquence totale de la dysplasie classée selon les différents degrés, a fait l’objet d’une étude rétrospective.

66 patients présentant des signes histologiques de dysplasie épithéliale ont été inclus dans une étude de surveillance systématique, et une attention particulière a été accordée à l’association entre cette anomalie et la gastrite chronique atrophique (G.C.A.).

Les résultats de l’étude montrent que les lésions de dysplasie légère sont fréquentes alors que les lésions de dysplasie modérée et sévère sont plus rares. La dysplasie, en particulier celle de degré de sévérité élevé, est associée à la gastrite chronique atrophique (G.C.A.).

Ce fait semble influencer l’évolution au cours du temps et la majorité des cas de dysplasie associée à une G.C.A. ont connu une évolution progressive et dans 4 cas, furent associés à un cancer gastrique.

Les lésions histologiques de dysplasie à haut degré de sévérité doivent être évaluées avec soin, en particulier lors d’une association avec une G.C.A., vu leur caractère de lésion à haut risque ou leur association avec un cancer de l’estomac.

Mots-clé s

cancer endoscopie estomac gastrite lé sions précancé reuses. 

Gastric epithelial dysplasia: experience of screening and follow-up

Summary

The overall incidence of mild, moderate or severe gastric epithelial dysplasia in an endoscopic series was retrospectively evaluated.

66 patients presenting dysplastic mucosal changes were included in a follow-up study, and particular attention was focused on the association of chronic atrophic gastritis (C.A.G) to epithelial dysplasia in affecting the evolution in time of this precancerous lesion.

The result of the study show that mild dysplastic changes are a frequent finding while moderate or severe dysplasia is less frequently documented. Dysplasia, particularly in its higher degree, associates with the presence of C.A.G. This, in turn, seems to affect the evolution in time of the lesion, since almost only the cases of epithelial dysplasia associated to C.A.G. show a progression and the four cases of gastric cancer in this study fell within this group.

Histological findings of high grade dysplasia must be carefully evaluated, particularly when associated to C.A.G., because of their relatively high risk of evolution to or association with gastric cancer.

Key-words

cancer endoscopy stomach gastritis precancerous lesions 

Références

  1. 1.
    BARWICK K.W. — Gastric epithelial dysplasia: how reliably can it be recognized, what doest it mean?,J. Clin. Gastroenterol, 1982, 4, 493–496.PubMedCrossRefGoogle Scholar
  2. 2.
    BORCHARD F. — Gastric dysplasia,Istocitopatologia, 1981, 3, 89–92.Google Scholar
  3. 3.
    CORREA P. — The epidemiology and pathogenesis of chronic gastritis: three etiologic entities,Cancer, 1982, 50, 2554–2565.PubMedGoogle Scholar
  4. 4.
    CUELLO C., CORREA P., ZARAMA G., LOPEZ J., MURRAY J., GORDILLO G. — Histopathology of gastric dysplasias, Correlations with gastric juice chemistry,Am. J. Sur. Pathol., 3, 6, 491–500.Google Scholar
  5. 5.
    FARINATI F., CARDIN F., COSTA F. — Precancerous conditions and gastric cancer. In: Peptic Secretion, clinical and pathophysiological features — Advances in Gastroenterology — by F. Di Mario, F. Vianello, M. Plebani, Piccin eds, Padua, Italy, 1985, 109–113.Google Scholar
  6. 6.
    FARINI R., ARSLAN PAGNINI C., FARINATI F., Di MARIO F., CARDIN F., VIANELLO F., RUGGE M., NACCARATO R. — Is mild gastric epithelial dysplasia an indication for follow-up?,J. Clin., Gastroenterol., 1983, 5, 307–310.CrossRefGoogle Scholar
  7. 7.
    FARINI R., FARINATI F., LEANDRO G., Di MARIO F., CECCHETTO A., NACCARATO R. — Gastric epithelial dysplasia in relapsing and non relapsing gastric ulcer.Am. J. Gastroenterol., 1982, 77, 844–853.PubMedGoogle Scholar
  8. 8.
    FENOGLIO CM., HAPGITT R.C., HAMILTON S.R., LUMB G., PASCAL R.R., RIDDEL R.H. — Colonic dysplasia (a symposium). In: Sommers S.C., Rosen P.P. edsPathol. Ann., 1981, 6, 1, 181–213.Google Scholar
  9. 9.
    GRANT N., STEMMERMAN M. — The impact of epidemiology upon the diagnosis and management of gastric disease: the experience of the Hawaii Japanese,Acta endosc., 1981, XI, 2, 103–122.Google Scholar
  10. 10.
    HEINZL S., SZALMAY G., JOCHUM L., ROEMER V. — Observations on the development of dysplasia, Acta Cytol., 1981, 453–456.Google Scholar
  11. 11.
    LAXEN F. — Gastric carcinoma and pernicious anaemia in long-term endoscopic follow-up of subjects with gastric polyps,Scand. J. Gastroenterol., 1984, 19, 535–540.PubMedGoogle Scholar
  12. 12.
    MAAROOS J., SALUPERE V., UIBO R. — Gastric ulcer, gastritis and gastric carcinoma,Ann. Clin. Res., 1981, 13, 151–153.PubMedGoogle Scholar
  13. 13.
    MING S.C. — Dysplasia of gastric epithelium,Fornt. Gastrointest. Rest., 1979, 4, 164–172.Google Scholar
  14. 14.
    MORSON B.C., SOBIN L.H., GRUNDMANN E., JOHANSEN A., NAGAYO T., SERCK-HANSSEN A. — Precancerous conditions and epithelial dysplasia in the stomach,J. Clin. Pathol., 1980, 33, 711–721.PubMedCrossRefGoogle Scholar
  15. 15.
    OEHLERT W., KELLER P., HENKE M., STRAUCH M. — Gastric mucosal dysplasia: what is its clinical significance?,Front. Gastrointest. Res., 1979, 4, 173–182.PubMedGoogle Scholar
  16. 16.
    POTET F., CAMILLERI J.P. — Population à haut risque et dysplasies pré cancé reuses de l’ estomac: dé finition et attitude pratique,Gastroenterol. Clin. Biol., 1985, 6 (5), 454–461.Google Scholar
  17. 17.
    RIDDELL R.H., GOLDMAN H., RANSHOFF D.F., APPELMAN H.D., FENOGLIO C.M., HAGGITT R.C., AHREN C., CORREA P., HAMILTON S.R., MORSON B.C., SOMMERS S.C., YARDLEY J.H. — Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Perspectives in Pathology,Hum. Pathol., 1983, 14, 11, 931–968.PubMedCrossRefGoogle Scholar
  18. 18.
    SAMLOFF I.M., IHAMAKIVARIS K., SIURALA M. — Effect of chronic gastritis on serum pepsinogen I and pepsinogen II levels,Gastroenterology, 76, 312, 1979.Google Scholar
  19. 19.
    SIPPONEN P. — Intestinal metaplasia and gastric carcinoma,Ann. Clin. Res., 1981, 13, 139–143.PubMedGoogle Scholar
  20. 20.
    SIPPONEN P., KEKKI M., HAAPAKOSKI J., IHAMAKI T., SIURALA M. — Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data,Int. J. Cancer, 1985, 35, 173–177.PubMedCrossRefGoogle Scholar
  21. 21.
    STRICKLAND R., MAC KAY I.R. — A reappraisal of the nature and significance of chronic atrophic gastritis,Dig. Dis., 1973, 18 (5), 426–440.CrossRefGoogle Scholar
  22. 22.
    WHITEHEAD R., TRUELOVE S.C., GEAR M.W. — The histological diagnosis of chronic gastritis in fibreoptic gastroscopy biopsy specimens,J. Clin. Pathol., 1972, 25, 1–11.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • F. Cardin
    • 1
  • F. Farinati
    • 1
  • F. Di Mario
    • 1
  • C. Arslan-Pagnini
    • 2
  • M. Rugge
    • 2
  • G. Penon
    • 1
  • R. Naccarato
    • 1
  1. 1.Cattedra Malattie Apparato Digerente - Istituto di Medicina Interna - Policlinico UniversitarioPadovaItaly
  2. 2.III Cattedra - Istituto di Anatomia Patologica - Università di PadovaItaly
  3. 3.Cattedra Malattie Apparato Digerente, Istituto di Medicina InternaPadovaItaly

Personalised recommendations